| 发明名称 |
5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 摘要 |
<p>A pharmaceutical composition comprises a PTH fragment and 5-CNAC for oral delivery. The PTH fragment is selected from PTH (1-28) to PTH (1-41). The composition is useful for stimulating new bone formation and the treatment or prevention of osteoporosis.</p> |
| 申请公布号 |
NZ531018(A) |
申请公布日期 |
2006.03.31 |
| 申请号 |
NZ20020531018 |
申请日期 |
2002.08.16 |
| 申请人 |
NOVARTIS AG |
发明人 |
AZRIA, MOISE;BATEMAN, SIMON DAVID |
| 分类号 |
A61K9/48;A61K31/198;A61K38/22;A61K38/29;A61K47/18;A61P5/18;A61P19/08;A61P19/10;(IPC1-7):A61K47/18 |
主分类号 |
A61K9/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
